Table 1.
Reference #, multiple analyses .1 and .2 | M | Endpoint | Lead author |
---|---|---|---|
13 | 27 | Suicide ideation/attempt | Bridge (2007) |
14 | 63 | Antibiotic‐associated diarrhea | Hempel (2012) |
15 | 15 | Risk of low birth weight | Kayentao (2013) |
16 | 15 | Venous thromboembolism | Nalluri (2008) |
17.1 | 8 | Lung injury | Neto (2012) |
17.2 | 9 | Mortality | Neto (2012) |
18.1 | 8 | Cardiovascular deaths | Nguyen (2011) |
18.2 | 11 | Prostate cancer‐specific mortality | Nguyen (2011) |
19.1 | 21 | Incident pancreatitis in 21 large statin trials | Preiss (2012) |
19.2 | 7 | Incident pancreatitis in 7 large fibrate trials | Preiss (2012) |
20 | 16 | Fatal adverse events | Ranpura (2011) |
21 | 17 | All‐cause mortality | Rizos (2012) |
22.1 | 17 | Major cardiovascular events—inhaled anticholinergics | Singh (2008) |
22.2 | 5 | Major cardiovascular events—long term Inhaled anticholinergics | Singh (2008) |
23.1 | 5 | Major cardiovascular events | Udell (2013) |
23.2 | 5 | Cardiovascular mortality | Udell (2013) |
24 | 25 | In hospital mortality | Wiener (2008) |
25 | 35 | Mortality | Zarychanski (2013) |
Studies where DerSimonian and Laird and Shuster, Guo and Skylar differ substantially are highlighted.
M = number of studies in analysis.